Viking Therapeutics (VKTX) Total Liabilities (2014 - 2026)
Viking Therapeutics (VKTX) posted Total Liabilities of $113.6 million for Q2 2026, up 6.82% sequentially from $106.3 million in Q1 2026, and up 250.67% YoY from $32.4 million in Q2 2025.
Viking Therapeutics (VKTX) Total Liabilities (2014 - 2026) Analysis & Trends
Viking Therapeutics has reported Total Liabilities for 13 years, with the latest figure at $113.6 million in Q2 2026.
- Quarterly Total Liabilities rose 250.67% year-over-year to $113.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $113.6 million (up 250.67% YoY) and the FY2025 annual result came in at $76.7 million, up 173.39% from the prior year.
- Total Liabilities rose to $113.6 million in Q2 2026 per VKTX's latest filing, from $106.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $113.6 million in Q2 2026 and troughed at $12.8 million in Q1 2022.
- A 5-year average of $34.6 million and a median of $24.5 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Liabilities plunged 40.3% in 2025, then soared 429.64% in 2026.
- Over 5 years, Total Liabilities stood at $23.2 million in 2022, then slipped by 13.51% to $20.1 million in 2023, then jumped by 39.72% to $28.0 million in 2024, then soared by 173.39% to $76.7 million in 2025, then soared by 48.15% to $113.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $113.6 million, $106.3 million, and $76.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Viking Therapeutics | 3.87 Bn | 3.87 Bn | - | 113.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.58 Mn |
| Mar 31, 2026 | 106.33 Mn |
| Dec 31, 2025 | 76.67 Mn |
| Sep 30, 2025 | 26.39 Mn |
| Jun 30, 2025 | 32.39 Mn |
| Mar 31, 2025 | 20.08 Mn |
| Dec 31, 2024 | 28.04 Mn |
| Sep 30, 2024 | 26.44 Mn |
| Jun 30, 2024 | 25.86 Mn |
| Mar 31, 2024 | 33.63 Mn |
| Dec 31, 2023 | 20.07 Mn |
| Sep 30, 2023 | 14.42 Mn |
| Jun 30, 2023 | 14.58 Mn |
| Mar 31, 2023 | 16.83 Mn |
| Dec 31, 2022 | 23.21 Mn |
| Sep 30, 2022 | 15.40 Mn |
| Jun 30, 2022 | 16.28 Mn |
| Mar 31, 2022 | 12.76 Mn |
| Dec 31, 2021 | 8.78 Mn |
| Sep 30, 2021 | 11.35 Mn |